Phathom Pharmaceuticals (PHAT) stock rises as Cantor Fitzgerald issues an Overweight rating, rejecting its IP-rights related ...

Cantor Fitzgerald reaffirmed its Overweight rating and $118.00 price target for Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company specializing in rare diseases. Currently ...

Cantor Fitzgerald initiated coverage of Phathom Pharmaceuticals (PHAT) with an Overweight rating and $23 price target The firm cited ...

Cantor Fitzgerald initiated coverage of Phathom Pharmaceuticals (PHAT) with an Overweight rating and $23 price target Maximize Your Portfolio ...

NOW OPEN: 200 Charter Memberships to Benzinga Trade Alerts While the firm remains the largest publicly traded corporate ...

The authors write "Post-employment restrictive covenants, once viewed as near fortresses to protect proprietary information, ...

The Senate Commerce, Science and Transportation Committee advanced Howard Lutnick’s nomination to lead the Commerce ...

President Trump has nominated Pierre Gentin, chief legal officer of the consulting giant McKinsey & Co. since 2019, to serve ...

Imsidolimab inhibits the function of the IL-36R, compensating for the deficiency of the endogenous IL-36 regulator in patients with GPP. Imsidolimab has successfully concluded its development program ...

Cantor Fitzgerald lowered the firm’s price target on Cigna (CI) to $350 from $400 and keeps an Overweight rating on the shares. Cantor is confident that Cigna can correct their stop-loss pricing ...

Hondius is an alternative investment manager. Prior to founding Hondius in 2018, Mr. Matthews was CEO of Cantor Fitzgerald & Co from 2009 to 2018. "Ucore has a world class technology that they are ...

Howard Lutnick, the president’s nominee, is the head of Cantor Fitzgerald LP, which serves as a key banking partner for the world’s largest issuer of stablecoins. During the hearing, Lutnick disclosed ...